UBS Predicts 10-14% Annual Earnings Growth for Cigna Group Through 2027
CICI•
UBS analysts rank Cigna Group among top managed-care ideas, citing absorbed PBM reform risks and greater visibility after shifting to a rebate-free model. They expect 10-14% annual earnings growth through 2027 and highlight the stock’s peer-relative discount plus potential share buyback resumption.
1. Analysts Highlight Rebate-Free Model Impact
UBS analysts argue that Cigna’s transition to a rebate-free pharmacy benefit management model reduces regulatory uncertainty and provides clearer revenue visibility, indicating that reform risks have already been priced in.
2. Earnings Growth Forecast and Valuation Opportunity
The firm projects 10-14% annual earnings growth through 2027, noting Cigna’s share price trades at a significant discount to peers and could attract additional support if the company resumes share repurchases.
Related News
ENHA
Enhanced Trial Shifts to Five-Year Monitoring After 91% Athlete Testosterone Use
ENHA•
NVDA
Nvidia Tops $91B Sales Forecast, Boosts Dividend and Buyback Program
NVDA•
NVDA
Nvidia posts $81.6bn Q1 revenue, raises dividend 25-fold and authorizes $80bn buyback
NVDA•
MS
Morgan Stanley to Co-Lead SpaceX’s $1.75T Nasdaq IPO with Four Banks
MS•
JAGX
Jaguar Health Q1 Revenue Jumps 816% to $20.3M on $19M License Deal
JAGX•
Sources
F